The Indian Competition Authority fines merging parties for failure to disclose global acquisition of the healthcase antisepsis business (Schulke / ASP Division of Ethicon)

CCI penalizes Schulke and Mayr GmBH (Schulke) for delayed filing in relation to the acquisition of Healthcare Antisepsis Solutions (HAS) business of Johnson & Johnson Private Limited (JJPL)* CCI, by its order dated January 13, 2017 has imposed a penalty of INR 25,00,000 on Schulke on account of their failure to notify the commission about its global acquisition of Ethicon Inc.’s Healthcare antisepsis (HAS) business. On April 23, 2015, Schulke has entered into a Global Asset Purchase Agreement (GAPA) for

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • Vaish Associates, Advocates (New Delhi)

Quotation

Man Mohan Sharma, The Indian Competition Authority fines merging parties for failure to disclose global acquisition of the healthcase antisepsis business (Schulke / ASP Division of Ethicon), 13 January 2017, e-Competitions Bulletin January 2017, Art. N° 87604

Visites 15

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues